The Hatch-Waxman Act: balancing competing interests or survival of the fittest?
Behrendt
Kristin E
KE
Darby & Darby, P.C., New York, NY, USA
D017277:Drug Approval; D016527:Drug Costs; D004345:Drug Industry / Q000191:economics / Q000331:legislation & jurisprudence*; D016568:Drugs, Generic; D004465:Economic Competition; D006801:Humans; D011356:Product Labeling / Q000331:legislation & jurisprudence; D013810:Therapeutic Equivalency; D014481:United States
D016568:Drugs, Generic